Glycopyrrolate API
A potent quaternary ammonium anticholinergic agent structurally engineered for advanced surgical secretion control and highly specific peptic ulcer therapies.
CAS Number
596-51-0
Formula
C₁₉H₂₈BrNO₃
Mol. Weight
398.33 g/mol
Grade
USP / EP / BP
Product Overview
Glycopyrrolate is an essential, highly-synthetic quaternary ammonium compound functioning prominently as a powerful muscarinic receptor antagonist. Radically differing from other structures, its specific quaternary amine profile distinctly prevents it from readily crossing the blood-brain barrier—giving it vastly immense clinical preference for yielding profoundly minimal central nervous system (CNS) interference.
Distributed comprehensively by Jay Overseas, this API reliably blocks acetylcholine actions effectively across crucial parasympathetic sites inside smoothly dense muscle tracts and highly sensitive secretory glands. We support extensive global formulations spanning from standard oral preparations up to highly regulated sterile injectable grades.
Barrier Repulsion
Minimizes severe CNS impairment by completely inhibiting blood-brain crossings.
Injectable Formulations
Bacterial endotoxin controls specifically audited explicitly for rapid intravenous use.
API Snapshot
Acetylcholine Blockade Mechanism
Muscarinic Receptor Inhibition
The API formally and highly competitively inhibits the explicit action of acetylcholine entirely at the muscarinic receptors (specifically mapping to M1, M2, and M3).
Parasympathetic Suppression
This targeted binding systematically blocks massive parasympathetic nerve impulses moving precisely across multiple glandular tissues.
Secretory Collapse
Provides heavily decreased systemic secretions from active salivary, heavy bronchial, and sweat glands directly lowering dangerous motility output.
Therapeutic Applications
Peptic Ulcer Treatment
Operates broadly as an adjunctive therapeutic control specifically for peptic ulcer diseases.
Secretory Reduction
Profoundly reduces salivary, tracheobronchial, and aggressive pharyngeal secretions.
Preoperative Anesthesia
Crucial preoperative antisialagogue deployment during complex anesthesia procedures.
Neuromuscular Reversal
Deployed critically to safely reverse neuromuscular blockade (when administered with neostigmine).
Manufacturing Excellence
Our Glycopyrrolate runs actively through state-of-the-art WHO-GMP certified locations executing rigorous, hyper-strict process validations. We fully execute optical rotation control methodologies and offer exclusive sterile synthesis outputs targeting high-risk acute injectables globally safely.
Parenteral Ready
USP 71 Sterility Certified
Documentation
Full Analytical Validations
Clinical Advantages & Profiling
Provides absolute superiority significantly beyond standard atropine bases, driving profoundly longer durations with substantially safer operative results globally.
Virtually negligible CNS effects perfectly driven by its highly specific quaternary structure
Offers a fundamentally longer duration of systematic action prominently compared to standard atropine
Operates clinically as a deeply more potent antisialagogue than baseline atropine formations
Uniquely available manufactured structurally for both complex oral and rigorous injectable formulations
Displays an exceedingly well-established, highly documented global clinical safety profile
Detailed USP Specifications
Sterile Injectable Profile Support Included
| Sr. | Test Parameter | Global Specification Limits |
|---|---|---|
| 1 | Description | White or practically white, odorless crystalline powder |
| 2 | Solubility | Freely soluble in water/alcohol, practically insoluble in chloroform |
| 3 | Identification | IR spectrum conforms to reference standard (USP) |
| 4 | pH (1% solution) | 4.5 – 7.0 |
| 5 | Specific Rotation | -23.0° to -26.0° (calculated on anhydrous basis) |
| 6 | Loss on Drying | Not more than 1.0% |
| 7 | Sulfated Ash | Not more than 0.1% |
| 8 | Related Substances (HPLC) | Any individual: NMT 0.5% | Total impurities: NMT 2.0% |
| 9 | Heavy Metals | NMT 20 ppm |
| 10 | Assay (Dried, HPLC) | 98.0% – 102.0% |
| 11 | Bacterial Endotoxins | NMT 0.5 EU/mg (Injectable Grade) |
| 12 | Sterility | Complies with USP <71> (Injectable Grade) |
Why Partner with Jay Overseas
Connecting your strict formulation profiles with universally validated, premium anticholinergic vectors.
Global Supply Capability
Reliable supply vectors extending fully to highly regulated international markets, fully secured with comprehensive technical and regulatory documentation.
Injectable Grade Purity
Rigorous internal quality control guaranteeing strict sterility metrics, heavily-controlled impurity profiling, and robustly low endotoxin measurements.
Regulatory Compliance
Produced consistently in WHO-GMP certified zones with USFDA DMFs rigidly filed, matching complete compliance to modern USP, EP, and BP pharmacopeial standards.
Sterile & Bulk Packaging
Double LDPE internal barriers protected strictly inside durable HDPE drums. Exclusive sterile-grade seals available instantly upon custom requests.
Room Temperature Storage
Store securely at controlled room temperatures mapping 20-25°C. Explicitly protect from aggressive light mapping and moisture degradation vectors.
Verified Stability Profiles
Engineered specifically to seamlessly maintain optimal clinical purity resulting directly in an extensive 36 Month formal operational shelf life.
Source Injectable & Oral Grade API
Speak globally with our specialized technical integration teams to initiate rapid sterile testing samples, comprehensive pricing breakdowns, and immediate USP documentation structures.
Legal Disclaimer: Glycopyrrolate API deeply operates as a strictly controlled clinical base asset. It is manufactured, securely distributed, and explicitly restricted heavily to licensed, regulatory compliant pharmaceutical execution entities for sterile and oral operations. Formulations absolutely remain non-consumable directly natively.